&Partners’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.35M Buy
28,322
+6,932
+32% +$321K 0.01% 1246
2026
Q1
$935K Sell
21,390
-170
-0.8% -$7.76K ﹤0.01% 1344
2025
Q4
$956K Buy
21,560
+1,164
+6% +$50.1K 0.01% 1243
2025
Q3
$861K Buy
20,396
+938
+5% +$37.8K 0.01% 1158
2025
Q2
$714K Buy
19,458
+6,139
+46% +$228K 0.01% 1161
2025
Q1
$628K Buy
13,319
+2,094
+19% +$77.9K 0.01% 1031
2024
Q4
$430K Buy
11,225
+3,887
+53% +$155K 0.01% 1140
2024
Q3
$299K Buy
+7,338
New +$278K 0.01% 1099

Other funds holding OHI

&Partners's OHI Position: Q2 2026 in Review

&Partners increased its Omega Healthcare (OHI) stake by 32% in Q2 2026, buying an estimated $321K and bringing the position to 28,322 shares worth $1.35M. The position accounts for 0.01% of the portfolio, ranked #1246.

&Partners first reported a position in OHI in Q3 2024 and has held it in 8 quarters since. 759 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • &Partners held 28,322 shares of Omega Healthcare worth $1.35M as of Q2 2026.
  • &Partners bought 6,932 Omega Healthcare shares in Q2 2026, an estimated $321K.
  • Omega Healthcare made up 0.01% of &Partners's portfolio in Q2 2026, its #1246 holding.
  • &Partners first reported a position in Omega Healthcare in Q3 2024 and has held it in 8 quarters since.
  • 759 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.